SEC Form 4 · accession 0001638599-16-001582
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ambra Thomas E D
Director · Other
Period of report
Nov 10, 2016
Accepted (ET)
Nov 17, 2016 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 10, 2016 | G | 700 | $0.00 | D | 2,490,146 | D | |
| Common StockF1 | Nov 10, 2016 | G | 2,000 | $0.00 | D | 2,488,146 | D | |
| Common StockF1 | Nov 14, 2016 | G | 10,000 | $0.00 | D | 2,478,146 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction is a bona fide gift from Dr. Thomas E. D Ambra and his spouse, Constance D Ambra.